Stay
up-to-date
about
RECOVER
Our understanding of Long COVID is constantly evolving with new research findings. Stay informed by reading the latest news and participating in upcoming events.
Researchers can learn how to access and use data from RECOVER’s pediatric observational study during the next BioData Catalyst® (BDC) Community Hours event, scheduled for Tuesday, December 3rd, 2024, at 1:00 pm EST.
On November 21, NIAID and FNIH launched its first in a series of online webinars highlighting recent progress in the new Researching COVID to Enhance Recovery - Treating Long COVID (RECOVER-TLC) program.
Recent findings from across RECOVER’s five research areas could improve our ability to identify people with Long COVID, understand the underlying causes of their symptoms, and provide them with care and treatment.
Studies used electronic health record (EHR) data to highlight Long COVID rates and risk factors, including the risk associated with repeated COVID-19 infections.
NIH leaders will discuss the current status of RECOVER-TLC, share information about potential Long COVID treatments to be tested in RECOVER-TLC clinical trials, and answer questions from the public.
RECOVER-TLC invites the Long COVID community to submit ideas for potential Long COVID treatments and biomarkers, volunteers for working groups, and provide feedback on the next phase of Long COVID clinical trials.
Researchers across NIH are sharing expertise, data, and innovative research tools to make discoveries that could help improve the lives of people with Long COVID.
A research team at RECOVER’s South Dakota study site prioritizes diversity and accessibility in clinical trial enrollment.
Media InquiriesAre you a member of the media or press? Please direct inquiries to the RECOVER@nih.gov inbox. Please place "MEDIA INQUIRY" in your subject line.